Related Experiment Video

Updated: Jan 10, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.1K

Economic Barriers to Interventional Cardiology Care for Adults and Children With Congenital Heart Disease and

Lyndon C Box1, Mark H Hoyer2, Sergio Bartakian3

  • 1West Valley Medical Center, Caldwell, Idaho.

Journal of the Society for Cardiovascular Angiography & Interventions
|November 21, 2025
PubMed

Insights

Economic barriers in the US healthcare system negatively impact congenital heart disease (CHD) patients needing interventional cardiology. Addressing these issues is crucial for improving patient outcomes and care delivery.

Area of Science:

  • Cardiology
  • Health Economics
  • Healthcare Policy

Background:

  • Congenital heart disease (CHD) necessitates complex interventional cardiology procedures.
  • These procedures require specialized physicians and significant resources.
  • The current US healthcare system presents economic challenges impacting CHD care.

Purpose of the Study:

  • To identify and analyze economic barriers affecting CHD patients in interventional cardiology.
  • To underscore the link between these barriers and suboptimal patient outcomes.
  • To advocate for systemic changes to improve care delivery for CHD patients.

Main Methods:

  • Analysis of economic factors within the US healthcare system related to interventional cardiology for CHD.
  • Review of payment structures, physician compensation, and device development costs.
  • Identification of policy and advocacy needs.

Main Results:

  • Economic barriers include issues with Medicaid payments, procedure valuation, physician compensation, and device development.
  • These combined factors contribute to poorer outcomes for CHD patients.
  • Current system inadequately supports resource-intensive CHD interventional cardiology.

Conclusions:

  • The Society for Cardiovascular Angiography & Interventions (SCAI) is dedicated to overcoming these economic barriers.
  • A coordinated effort involving advocacy and education is required.
  • New approaches are needed to ensure optimal interventional cardiology care for CHD patients.

Keywords:
MedicaidUS Food and Drug Administrationadvocacycongenital heart diseaseinterventional cardiology

More Related Videos

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

4.1K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.3K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
316
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
378
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.0K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
449
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
224